Id: CBI_2395 | Pages: 221 | Format : PDF | Published : | Author : Consegic Business Intelligence | Category : Healthcare
The aortic valve market size is growing with a CAGR of 14.2% during the forecast period (2025-2032), and the market is projected to be valued at USD 40,545.65 Million by 2032 from USD 14,019.96 Million in 2024. Additionally, the market value for the 2025 attributes to USD 15,966.75 Million.
Aortic valve is a medical device which used to replace the damaged aortic valve in the patients. It mainly consists of leaflets or cusps, suture ring, and occluder disc. The aortic valve is of two types mechanical and biological. Further, mechanical valve consists of carbon or titanium and other sturdy materials while biological valve is made of cow tissue, pig tissue or human tissue. Aortic valve helps in restoring normal blood flow from the left ventricle to the aorta in patients. It is implanted through open surgery and and minimally invasive surgery. Moreover, aortic valve is utilized by hospitals, cardiac centers, ambulatory surgical centers, and others in the treatment of aortic stenosis and aortic regurgitation.
Aortic stenosis is a narrowing of the aortic valve opening and restricts the blood flow from the left ventricle to the aorta. Aortic valve is a device which replaces the damaged tissues of the aortic stenosis and restores the blood flow from the left ventricle to the aorta. The incidence of aortic stenosis is increasing due to several factors such as high blood pressure, diabetes, and chronic kidney disease, further driving the market.
Thus, the high incidence of aortic stenosis is leading to aortic valve market demand.
Favorable government policies are major driver in the market. It includes increasing reimbursement for surgical valve repair including aortic valve. The reimbursement is increased by updating current reimbursement rates according to the expenditure. This is helping more patients to opt for surgical treatment options. Further, the government is also investing in the payments for surgical valve procedures to enhance treatment access among the patients.
Hence, favorable government policies are leading to aortic valve market expansion.
The aortic valve is a medical device and hence their manufactures must adhere to regulatory standards for safety, performance and biocompatibility. Authorities such as United States Food and Drug Administration, European Medicines Agency (EMA) impose rigorous testing and documentation requirement for this valve before it is approved for clinical use. These regulations ensure that the aortic valve does not cause harm, function effectively in treatment and meet the required quality standards. The approval process involves multiple stages, including preclinical trials, testing, biocompatibility evaluations and clinical trials, which are time-intensive and costly. It typically causes delays due to lengthy evaluations of additional requirements for compliance. Thus, stringent regulatory approvals are constraining the market demand due to increased costs and limited availability of advanced technology.
Product innovations are increasing the applicability of aortic valve. It includes frame markers and bovine pericardium. Frame markers are ensuring precise implantation and ease of deployment. Bovine pericardium is increasing the durability and reliability of the valve. Moreover, companies are also developing valves with advanced design.
Thus, product innovations such as supra-annular design are expected to create aortic valve market opportunities.
Based on product type, the market is categorized into mechanical and biological.
Trends in Product Type
The mechanical segment accounted for the largest market share in the year 2024.
The biological segment is expected to grow at the fastest CAGR over the forecast period.
Based on procedure, the market is categorized into open surgery and minimally invasive surgery.
Trends in Procedure
The open surgery segment accounted for the largest market share in the year 2024.
The minimal invasive surgery segment is expected to grow at the fastest CAGR over the forecast period.
Based on end-user, the market is categorized into hospitals, cardiac centers, ambulatory surgical centers, and others.
Trends in End-User
The hospitals segment accounted for the largest market share of 54.78% in the year 2024.
The ambulatory surgical centers segment is expected to grow at the fastest CAGR over the forecast period.
The regions covered are North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.
In 2024, North America accounted for the highest market share at 38.97% and was valued at USD 5,463.58 Million and is expected to reach USD 14,690.33 Million in 2032. In North America, United States accounted for the highest market share of 72.08% during the base year of 2024. The aortic valve market share of the North America region is major due to technological advancements. Technological advancements in valve design and surgical techniques have enhanced the applicability of aortic valve. Moreover, companies are developing valve with advanced features for easy implantation further driving the market.
Thus, North America is leading in the market due to technological advancements and advanced healthcare technology as per analysis.
Asia-pacific is expected to witness the fastest CAGR of 16.2% over the forecast period during 2025-2032. According to aortic valve market analysis, the Asia Pacific region is growing rapidly driven by rising prevalence of cardiovascular diseases. Countries such as China, India, Japan, and South Korea are major contributors in the market due to growing cases of aortic stenosis and congenital heart disease. The increasing number of hospitals and cardiac centers is further driving the adoption of aortic valve in the treatment of patients. Hence, theaortic valve market share of Asia Pacific is experiencing rapid growth through rising prevalence of cardiovascular diseases as per market analysis.
According to aortic valve market analysis, Europe region is experiencing steady growth in the market driven by increasing heath expenditure. The region is well developed with modern diagnostic technology and skilled cardiologists along with digital healthcare infrastructure. The government in the region is also investing in research and development of aortic valve with advanced features for faster patient recovery and easy implantation during surgical procedures. It is further leading to aortic valve market expansion in the region.
The Middle East and Africa region is experiencing gradual demand in the market, driven by increasing awareness about cardiac health and improving healthcare industry. Countries such as Dubai, UAE, and South Arica are major contributors in the market where advanced hospitals and government organizations provide access to advanced treatments including aortic valve. Further, the ambulatory surgical centers in the region are offering minimally invasive surgery for less trauma and improved clinical outcomes as per analysis.
As per analysis, the market in Latin America is driven by rising disposable income and growing population. Countries such as Brazil, Mexico and Argentina are major contributors in the region due to modern healthcare infrastructure. The rise of diagnostic centers and private clinics has significantly impacted the availability of advanced cardiac diagnostic methods for aortic stenosis. Additionally, patients in the region are preferring biological valve for less complications and faster recovery.
The aortic valve industry is highly competitive with major players providing products to the national and international markets. Key players are adopting several strategies in research and development (R&D) and product innovation to hold a strong position in the global aortic valve market. Key players in aortic valve industry include-
Partnerships & Collaborations:
Mergers and Acquisitions
Report Attributes | Report Details |
Study Timeline | 2019-2032 |
Market Size in 2032 | USD 40,545.65 Million |
CAGR (2025-2032) | 14.2% |
By Product Type |
|
By Procedure |
|
By End-User |
|
By Region |
|
Key Players |
|
North America | U.S. Canada Mexico |
Europe | U.K. Germany France Spain Italy Russia Benelux Rest of Europe |
APAC | China South Korea Japan India Australia ASEAN Rest of Asia-Pacific |
Middle East and Africa | GCC Turkey South Africa Rest of MEA |
LATAM | Brazil Argentina Chile Rest of LATAM |
Report Coverage |
|
In 2024, the aortic valve market is USD 14,019.96 million.
Asia Pacific is the fastest-growing region in the aortic valve market.
Product Type, Procedure, and End-User are covered in the aortic valve market.
Boston Scientific Corporation (United States), Medtronic (Ireland), and LivaNova PLC (United Kingdom) are some of the major players in the market.